reviewCancer Treatment ReviewsMar 6, 2008Closed access

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review

KGKiran GuptaJDJeffrey D. MillerJZJim Z. LiMWMason W. RussellCCClaudie Charbonneau

Abt Global (United States) · Pfizer (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,001
total citations
FWCI
21.81
Percentile
100%
References
75
Citations per year

Authors

5

Topics & keywords

Topics
Keywords
  • Medicine
  • Renal cell carcinoma
  • Sunitinib
  • Sorafenib
  • Disease burden
  • Population
  • Disease
  • Incidence (geometry)
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding